Reduced dopamine receptor sensitivity as an intermediate phenotype in alcohol dependence and the role of the COMT Val158Met and DRD2 Taq1A genotypes

Archives of General Psychiatry

Volumn 69, Issue 4, 2012, Pages 339-348

  Schellekens, Arnt F A ^a,b,c,e   Franke, Barbara ^a,b   Ellenbroek, Bart ^f   Cools, Alexander ^b   De Jong, Cor A J ^c,e   Buitelaar, Jan K ^b   Verkes, Robbert Jan ^a,b,d  

^a RADBOUD UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d Pompestichting   (Netherlands)

^e Novadic Kentron   (Netherlands)

^f VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; CATECHOL METHYLTRANSFERASE; DOPAMINE RECEPTOR; GROWTH HORMONE;

ADULT; ADVERTIZING; ALCOHOLISM; ARTICLE; CASE CONTROL STUDY; COGNITION; CONTROLLED STUDY; DETOXIFICATION; DOPAMINERGIC SYSTEM; EDUCATIONAL STATUS; GENOTYPE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MALE; OUTCOME ASSESSMENT; PHARMACOGENETICS; PHENOTYPE; PREDICTION; PREFRONTAL CORTEX; PROVOCATION TEST; PUBLICATION; RECEPTOR SENSITIVITY; RHOMBENCEPHALON; TASK PERFORMANCE;

ADULT; ALCOHOLISM; APOMORPHINE; CATECHOL O-METHYLTRANSFERASE; COGNITION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GROWTH HORMONE; HUMANS; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; PSYCHOMOTOR PERFORMANCE; RECEPTORS, DOPAMINE D2;

EID: 84859449326     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2011.1335     Document Type: Article

References (84)

1. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology. 2009;56(suppl 1):3-8.
2. Koob GF. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction. 2006;101(suppl 1):23-30. (Pubitemid 44199493)
3. Bienvenu OJ, Davydow DS, Kendler KS. Psychiatric "diseases" versus behavioral disorders and degree of genetic influence. Psychol Med. 2011;41(1):33-40.
4. Stacey D, Clarke TK, Schumann G. The genetics of alcoholism. Curr Psychiatry Rep. 2009;11(5):364-369.
5. Goldman D, Ducci F. Deconstruction of vulnerability to complex diseases: enhanced effect sizes and power of intermediate phenotypes. Scientific World Journal. 2007;7:124-130. (Pubitemid 350277590)
6. Hines LM, Ray L, Hutchison K, Tabakoff B. Alcoholism: the dissection for endophenotypes. Dialogues Clin Neurosci. 2005;7(2):153-163. (Pubitemid 40961535)
7. Kendler KS, Neale MC. Endophenotype: a conceptual analysis. Mol Psychiatry. 2010;15(8):789-797.
8. Puls I, Gallinat J. The concept of endophenotypes in psychiatric diseases meeting the expectations? Pharmacopsychiatry. 2008;41(suppl 1):S37-S43.
9. Walters JT, Owen MJ. Endophenotypes in psychiatric genetics. Mol Psychiatry. 2007;12(10):886-890. (Pubitemid 47482705)
10. Flint J, Munafò MR. The endophenotype concept in psychiatric genetics. Psychol Med. 2007;37(2):163-180. (Pubitemid 46158160)
11. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160(4):636-645. (Pubitemid 41079594)
12. Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry. 2010;167(5):509-527.
13. Koob GF. Alcoholism: allostasis and beyond. Alcohol Clin Exp Res. 2003;27(2):232-243. (Pubitemid 36236646)
14. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F, Baler R. Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit. Bioessays. 2010;32(9):748-755.
15. Nader MA, Czoty PW. PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation. Am J Psychiatry. 2005;162(8):1473-1482. (Pubitemid 41105561)
16. Pierce RC, Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev. 2006;30(2):215-238. (Pubitemid 41821810)
17. Heinz A, Lichtenberg-Kraag B, Baum SS, Graf K, Kruger F, Dettling M, Rommelspacher H. Evidence for prolonged recovery of dopaminergic transmission after detoxification in alcoholics with poor treatment outcome. J Neural Transm Gen Sect. 1995;102(2):149-157.
18. Heinz A, Sander T, Harms H, Finckh U, Kuhn S, Dufeu P, Dettling M, Gräf K, Rolfs A, Rommelspacher H, Schmidt LG. Lack of allelic association of dopamine D1 and D2 (TaqIA) receptor gene polymorphisms with reduced dopaminergic sensitivity to alcoholism. Alcohol Clin Exp Res. 1996;20(6):1109-1113. (Pubitemid 26314839)
19. Lucht M, Samochowiec A, Samochowiec J, Jasiewicz A, Grabe HJ, Geissler I, Rimmbach C, Rosskopf D, Grzywacz A, Wysiecka JP, Tybura P, Brzuchalski B, Bieńkowski P. Influence of DRD2 and ANKK1 genotypes on apomorphineinduced growth hormone (GH) response in alcohol-dependent patients. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(1):45-49.
20. Schellekens AF, van Oosterwijck AW, Ellenbroek B, de Jong CA, Buitelaar JK, Cools L, Verkes RJ. The dopamine agonist apomorphine differentially affects cognitive performance in alcohol dependent patients and healthy controls. Eur Neuropsychopharmacol. 2009;19(1):68-73.
21. Schmidt LG, Dettling M, Graef KJ, Heinz A, Kuhn S, Podschus J, Rommelspacher H. Reduced dopaminergic function in alcoholics is related to severe dependence. Biol Psychiatry. 1996;39(3):193-198. (Pubitemid 26074216)
22. Noble EP. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet. 2003;116B(1):103-125. (Pubitemid 37063624)
23. Noble EP. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. Eur Psychiatry. 2000;15(2):79-89. (Pubitemid 30194150)
24. Tanji J, Hoshi E. Role of the lateral prefrontal cortex in executive behavioral control. Physiol Rev. 2008;88(1):37-57.
25. Knoch D, Fehr E. Resisting the power of temptations: the right prefrontal cortex and self-control. Ann N Y Acad Sci. 2007;1104:123-134. (Pubitemid 47092730)
26. Yücel M, Lubman DI. Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention. Drug Alcohol Rev. 2007;26(1):33-39.
27. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol. 2007;64(11):1575-1579. (Pubitemid 350106758)
28. Schellekens AF, Grootens KP, Neef C, Movig KL, Buitelaar JK, Ellenbroek B, Verkes RJ. Effect of apomorphine on cognitive performance and sensorimotor gating in humans. Psychopharmacology (Berl). 2010;207(4):559-569.
29. Sautter F, Garver DL, Zemlan FP, Hirschowitz J. Growth hormone response to apomorphine and family patterns of illness. Biol Psychiatry. 1987;22(6):717-724. (Pubitemid 17101480)
30. Ellenbroek BA, Sluyter F, Cools AR. The role of genetic and early environmental factors in determining apomorphine susceptibility. Psychopharmacology (Berl). 2000;148(2):124-131. (Pubitemid 30104133)
31. Swerdlow NR, Shoemaker JM, Platten A, Pitcher L, Goins J, Auerbach PP. Heritable differences in the dopaminergic regulation of sensorimotor gating, I: apomorphine effects on startle gating in albino and hooded outbred rat strains and their F1 and N2 progeny. Psychopharmacology (Berl). 2004;174(4):441-451. (Pubitemid 39119334)
32. Laine TP, Ahonen A, Räsänen P, Pohjalainen T, Tiihonen J, Hietala J. The A1 allele of the D2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics. Alcohol Alcohol. 2001;36(3):262-265. (Pubitemid 32519863)
33. Jönsson EG, Nöthen MM, Grünhage F, Farde L, Nakashima Y, Propping P, Sedvall GC. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry. 1999;4(3):290-296. (Pubitemid 29292183)
34. Le Foll B, Gallo A, Le Strat Y, Lu L, Gorwood P. Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav Pharmacol. 2009;20(1):1-17.
35. Berggren U, Fahlke C, Aronsson E, Karanti A, Eriksson M, Blennow K, Thelle D, Zetterberg H, Balldin J. The taqI DRD2 A1 allele is associated with alcoholdependence although its effect size is small. Alcohol Alcohol. 2006;41(5):479-485. (Pubitemid 44404463)
36. Munafò MR, Johnstone EC, Welsh KI, Walton RT. Association between the DRD2 gene Taq1A (C32806T) polymorphism and alcohol consumption in social drinkers. Pharmacogenomics J. 2005;5(2):96-101. (Pubitemid 40468116)
37. Finckh U, Rommelspacher H, Kuhn S, Dufeu P, Otto G, Heinz A, Dettling M, Giraldo- Velasquez M, Pelz J, Gräf KJ, Harms H, Sander T, Schmidt LG, Rolfs A. Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism. Pharmacogenetics. 1997;7(4):271-281.
38. Wiesbeck GA, Dürsteler-MacFarland KM, Wurst FM, Walter M, Petitjean S, Müller S, Wodarz N, Böning J. No association of dopamine receptor sensitivity in vivo with genetic predisposition for alcoholism and DRD2/DRD3 gene polymorphisms in alcohol dependence. Addict Biol. 2006;11(1):72-75. (Pubitemid 46696737)
39. Berlin I, de Brettes B, Aymard G, Diquet B, Arnulf I, Puech AJ. Dopaminergic drug response and the genotype (Taq IA polymorphism) of the dopamine D2 receptor. Int J Neuropsychopharmacol. 2000;3(1):35-43. (Pubitemid 30354450)
40. Fan L, Bellinger F, Ge YL, Wilce P. Genetic study of alcoholism and novel gene expression in the alcoholic brain. Addict Biol. 2004;9(1):11-18. (Pubitemid 38608481)
41. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, Egan MF, Kleinman JE, Weinberger DR. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet. 2004;75(5):807-821. (Pubitemid 39390488)
42. Diamond A. Consequences of variations in genes that affect dopamine in prefrontal cortex. Cereb Cortex. 2007;17(suppl 1):i161-i170.
43. 158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A. 2003;100(10):6186-6191.
44. Kweon YS, Lee HK, Lee CT, Pae CU. Association study of catechol-O-methyltransferase gene polymorphism in Korean male alcoholics. Psychiatr Genet. 2005;15(2):151-154. (Pubitemid 40806870)
45. Ishiguro H, Haruo Shibuya T, Toru M, Saito T, Arinami T. Association study between high and low activity polymorphism of catechol-O-methyltransferase gene and alcoholism. Psychiatr Genet. 1999;9(3):135-138. (Pubitemid 30068196)
46. Tiihonen J, Hallikainen T, Lachman H, Saito T, Volavka J, Kauhanen J, Salonen JT, Ryynänen OP, Koulu M, Karvonen MK, Pohjalainen T, Syvälahti E, Hietala J. Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism. Mol Psychiatry. 1999;4(3):286-289. (Pubitemid 29292182)
47. Samochowiec J, Kucharska-Mazur J, Grzywacz A, Pelka-Wysiecka J, Mak M, Samochowiec A, Bienkowski P. Genetics of Lesch's typology of alcoholism. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(2):423-427. (Pubitemid 351178960)
48. Samochowiec J, Kucharska-Mazur J, Grzywacz A, Jabłoński M, Rommelspacher H, Samochowiec A, Sznabowicz M, Horodnicki J, Sagan L, Pełka-Wysiecka J. Family-based and case-control study of DRD2, DAT, 5HTT, COMTgenes polymorphisms in alcohol dependence. Neurosci Lett. 2006;410(1):1-5. (Pubitemid 44667246)
49. Foroud T, Wetherill LF, Dick DM, Hesselbrock V, Nurnberger JI Jr, Kramer J, Tischfield J, Schuckit M, Bierut LJ, Xuei X, Edenberg HJ. Lack of association of alcohol dependence and habitual smoking with catechol-O-methyltransferase. Alcohol Clin Exp Res. 2007;31(11):1773-1779. (Pubitemid 47609642)
50. Hallikainen T, Lachman H, Saito T, Volavka J, Kauhanen J, Salonen JT, Ryynänen OP, Koulu M, Karvonen MK, Pohjalainen T, Syvälahti E, Hietala J, Tiihonen J. Lack of association between the functional variant of the catechol-O-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior. Am J Med Genet. 2000;96(3):348-352.
51. Ossewaarde L, van Wingen GA, Kooijman SC, Bäckström T, Fernández G, Hermans EJ. Changes in functioning ofmesolimbic incentive processing circuits during the premenstrual phase. Soc Cogn Affect Neurosci. 2011;6(5):612-620.
52. Colzato LS, Hertsig G, van den Wildenberg WP, Hommel B. Estrogen modulates inhibitory control in healthy human females: evidence from the stop-signal paradigm. Neuroscience. 2010;167(3):709-715.
53. Weiner J, Sun WL, Zhou L, Kreiter CM, Jenab S, Quiñones-Jenab V. PKA-mediated responses in females' estrous cycle affect cocaine-induced responses in dopamine-mediated intracellular cascades. Neuroscience. 2009;161(3):865-876.
54. Czoty PW, Riddick NV, Gage HD, Sandridge M, Nader SH, Garg S, Bounds M, Garg PK, Nader MA. Effect of menstrual cycle phase on dopamine D2 receptor availability in female cynomolgus monkeys. Neuropsychopharmacology. 2009;34(3):548-554.
55. Dreher JC, Schmidt PJ, Kohn P, Furman D, Rubinow D, Berman KF. Menstrual cycle phase modulates reward-related neural function in women. Proc Natl Acad Sci U S A. 2007;104(7):2465-2470. (Pubitemid 46391419)
56. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9(3):199-213.
57. Rikoon SH, Cacciola JS, Carise D, Alterman AI, McLellan AT. Predicting DSM-IV dependence diagnoses from Addiction Severity Index composite scores. J Subst Abuse Treat. 2006;31(1):17-24. (Pubitemid 43928413)
58. Lehman AF, Myers CP, Dixon LB, Johnson JL. Detection of substance use disorders among psychiatric inpatients. J Nerv Ment Dis. 1996;184(4):228-233. (Pubitemid 26151702)
59. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33. (Pubitemid 29001829)
60. van Vliet IM, de Beurs E. The MINI-International Neuropsychiatric Interview: a brief structured diagnostic psychiatric interview for DSM-IV and ICD-10 psychiatric disorders [in Dutch]. Tijdschr Psychiatr. 2007;49(6):393-397.
61. Sandra Kooij JJ, Marije Boonstra A, Swinkels SH, Bekker EM, de Noord I, Buitelaar JK. Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients. J Atten Disord. 2008;11(4):445-458.
62. Hewlett P, Smith A. Acute effects of caffeine in volunteers with different patterns of regular consumption. Hum Psychopharmacol. 2006;21(3):167-180. (Pubitemid 43670666)
63. Domier CP, Monterosso JR, Brody AL, Simon SL, Mendrek A, Olmstead R, Jarvik ME, Cohen MS, London ED. Effects of cigarette smoking and abstinence on Stroop task performance. Psychopharmacology (Berl). 2007;195(1):1-9. (Pubitemid 47568618)
64. Watson DE, Li B. TaqMan applications in genetic and molecular toxicology. Int J Toxicol. 2005;24(3):139-145. (Pubitemid 40993361)
65. Essink AW, Lohuis CP, Klein Elhorst JT, Rutten WJ. Selective and quantitative isolation and determination of apomorphine in human plasma. J Chromatogr. 1991;570(2):419-424.
66. van der Linden D, Massar SA, Schellekens AF, Ellenbroek BA, Verkes RJ. Disrupted sensorimotor gating due to mental fatigue: preliminary evidence. Int J Psychophysiol. 2006;62(1):168-174. (Pubitemid 44307374)
67. Braver TS, Barch DM, Kelley WM, Buckner RL, Cohen NJ, Miezin FM, Snyder AZ, Ollinger JM, Akbudak E, Conturo TE, Petersen SE. Direct comparison of prefrontal cortex regions engaged by working and long-term memory tasks. Neuroimage. 2001;14(1, pt 1):48-59. (Pubitemid 32552742)
68. Allele frequency database. http://alfred.med.yale.edu/alfred/. Accessed October 22, 2011.
69. Balldin JI, Berggren UC, Lindstedt G. Neuroendocrine evidence for reduced dopamine receptor sensitivity in alcoholism. Alcohol Clin Exp Res. 1992;16(1):71-74.
70. Neville MJ, Johnstone EC, Walton RT. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat. 2004;23(6):540-545. (Pubitemid 38720604)
71. Dubertret C, Gouya L, Hanoun N, Deybach JC, Adès J, Hamon M, Gorwood P. The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia. Schizophr Res. 2004;67(1):75-85. (Pubitemid 38117094)
72. Lucht M, Rosskopf D. Comment on "Genetically determined differences in learning from errors." Science. 2008;321(5886):200.
73. Dick DM, Wang JC, Plunkett J, Aliev F, Hinrichs A, Bertelsen S, Budde JP, Goldstein EL, Kaplan D, Edenberg HJ, Nurnberger J Jr, Hesselbrock V, Schuckit M, Kuperman S, Tischfield J, Porjesz B, Begleiter H, Bierut LJ, Goate A. Family-based association analyses of alcohol dependence phenotypes across DRD2 and neighboring gene ANKK1. Alcohol Clin Exp Res. 2007;31(10):1645-1653. (Pubitemid 47390031)
74. Delawalla Z, Csernansky JG, Barch DM. Prefrontal cortex function in nonpsychotic siblings of individuals with schizophrenia. Biol Psychiatry. 2008;63(5):490-497. (Pubitemid 351220783)
75. MacDonald AW III, Carter CS. Event-related FMRI study of context processing in dorsolateral prefrontal cortex of patients with schizophrenia. J Abnorm Psychol. 2003;112(4):689-697. (Pubitemid 37509614)
76. Perlstein WM, Dixit NK, Carter CS, Noll DC, Cohen JD. Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia. Biol Psychiatry. 2003;53(1):25-38. (Pubitemid 36050933)
77. Silberstein RB, Farrow M, Levy F, Pipingas A, Hay DA, Jarman FC. Functional brain electrical activity mapping in boys with attention-deficit/ hyperactivity disorder. Arch Gen Psychiatry. 1998;55(12):1105-1112. (Pubitemid 28558283)
78. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A. 2001;98(12):6917-6922. (Pubitemid 32538317)
79. Stein DJ, Newman TK, Savitz J, Ramesar R. Warriors versus worriers: the role of COMT gene variants. CNS Spectr. 2006;11(10):745-748. (Pubitemid 44571738)
80. Heinz A, Smolka MN. The effects of catechol-O-methyltransferase genotype on brain activation elicited by affective stimuli and cognitive tasks. Rev Neurosci. 2006;17(3):359-367. (Pubitemid 44077517)
81. Heinz A, Dufeu P, Kuhn S, Dettling M, Gräf K, Kürten I, Rommelspacher H, Schmidt LG. Psychopathological and behavioral correlates of dopaminergic sensitivity in alcohol-dependent patients. Arch Gen Psychiatry. 1996;53(12):1123-1128. (Pubitemid 26422064)
82. Swerdlow NR, Platten A, Hanlon FM, Martinez ZA, Printz MP, Auerbach P. Sensitivity to sensorimotor gating-disruptive effects of apomorphine in two outbred parental rat strains and their F1 and N2 progeny. Neuropsychopharmacology. 2003;28(2):226-234.
83. Farren CK, Tipton KF. Trait markers for alcoholism: clinical utility. Alcohol Alcohol. 1999;34(5):649-665. (Pubitemid 29467055)
84. Nader MA, Morgan D, Gage HD, Nader SH, Calhoun TL, Buchheimer N, Ehrenkaufer R, Mach RH. PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci. 2006;9(8):1050-1056. (Pubitemid 44264918)